| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 34 | 2025 | 2518 | 2.200 |
Why?
|
| Breast | 13 | 2024 | 213 | 1.330 |
Why?
|
| Papilloma, Intraductal | 3 | 2013 | 5 | 0.800 |
Why?
|
| Carcinoma, Ductal, Breast | 6 | 2014 | 85 | 0.660 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 5 | 2014 | 63 | 0.580 |
Why?
|
| Carcinoma, Papillary | 4 | 2005 | 71 | 0.540 |
Why?
|
| Biopsy, Needle | 7 | 2011 | 228 | 0.520 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 3 | 2025 | 50 | 0.520 |
Why?
|
| Carcinoma, Lobular | 3 | 2014 | 24 | 0.510 |
Why?
|
| Epithelial Cells | 6 | 2024 | 909 | 0.490 |
Why?
|
| Precancerous Conditions | 4 | 2023 | 284 | 0.480 |
Why?
|
| Breast Diseases | 2 | 2011 | 35 | 0.420 |
Why?
|
| Lymph Nodes | 5 | 2017 | 378 | 0.390 |
Why?
|
| Mucocele | 1 | 2011 | 8 | 0.360 |
Why?
|
| Single-Cell Analysis | 3 | 2024 | 291 | 0.350 |
Why?
|
| Carcinoma in Situ | 2 | 2008 | 71 | 0.340 |
Why?
|
| Neoplasm Invasiveness | 6 | 2021 | 625 | 0.340 |
Why?
|
| STAT5 Transcription Factor | 2 | 2022 | 88 | 0.340 |
Why?
|
| Receptor, ErbB-2 | 6 | 2019 | 514 | 0.330 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2022 | 635 | 0.330 |
Why?
|
| Cadherins | 2 | 2013 | 172 | 0.330 |
Why?
|
| Hyperplasia | 5 | 2023 | 200 | 0.330 |
Why?
|
| Head and Neck Neoplasms | 3 | 2007 | 503 | 0.290 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2007 | 10 | 0.290 |
Why?
|
| Female | 40 | 2024 | 66709 | 0.270 |
Why?
|
| Mammography | 4 | 2018 | 114 | 0.270 |
Why?
|
| Biomarkers, Tumor | 4 | 2019 | 1534 | 0.260 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2006 | 29 | 0.250 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2007 | 669 | 0.240 |
Why?
|
| Artifacts | 1 | 2005 | 109 | 0.230 |
Why?
|
| Thyroid Neoplasms | 4 | 2017 | 189 | 0.230 |
Why?
|
| Cell Lineage | 3 | 2024 | 350 | 0.230 |
Why?
|
| Neoplasm Metastasis | 5 | 2021 | 705 | 0.220 |
Why?
|
| Mass Spectrometry | 3 | 2024 | 335 | 0.220 |
Why?
|
| Aneuploidy | 1 | 2024 | 153 | 0.220 |
Why?
|
| Humans | 48 | 2025 | 125116 | 0.210 |
Why?
|
| Mammary Glands, Animal | 4 | 2022 | 478 | 0.210 |
Why?
|
| Stem Cells | 4 | 2018 | 710 | 0.210 |
Why?
|
| Middle Aged | 16 | 2024 | 26682 | 0.200 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2023 | 75 | 0.200 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2006 | 237 | 0.200 |
Why?
|
| Thiazoles | 1 | 2023 | 98 | 0.200 |
Why?
|
| Calcinosis | 3 | 2013 | 181 | 0.200 |
Why?
|
| Diagnosis, Differential | 4 | 2018 | 1893 | 0.200 |
Why?
|
| Ultrasonography, Mammary | 4 | 2018 | 28 | 0.190 |
Why?
|
| Cell Line, Tumor | 7 | 2021 | 3422 | 0.190 |
Why?
|
| RNA | 1 | 2025 | 576 | 0.190 |
Why?
|
| Metabolomics | 1 | 2025 | 422 | 0.180 |
Why?
|
| Mice | 16 | 2023 | 17739 | 0.180 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2019 | 139 | 0.170 |
Why?
|
| Neoplasms | 3 | 2025 | 2794 | 0.170 |
Why?
|
| Receptors, Estrogen | 3 | 2018 | 794 | 0.170 |
Why?
|
| Adult | 14 | 2024 | 29465 | 0.170 |
Why?
|
| Lung Neoplasms | 3 | 2025 | 1654 | 0.170 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2014 | 65 | 0.170 |
Why?
|
| Wnt Proteins | 1 | 2021 | 216 | 0.170 |
Why?
|
| Gene Expression Profiling | 2 | 2024 | 1757 | 0.160 |
Why?
|
| ErbB Receptors | 1 | 2021 | 284 | 0.160 |
Why?
|
| Uridine Diphosphate Glucose Dehydrogenase | 1 | 2019 | 5 | 0.160 |
Why?
|
| DNA Copy Number Variations | 1 | 2024 | 963 | 0.160 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 121 | 0.160 |
Why?
|
| Codon | 1 | 2019 | 98 | 0.150 |
Why?
|
| Cinnamates | 1 | 2018 | 15 | 0.150 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 296 | 0.150 |
Why?
|
| Transcriptome | 1 | 2025 | 978 | 0.150 |
Why?
|
| Granulomatous Mastitis | 1 | 2018 | 6 | 0.150 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2018 | 106 | 0.150 |
Why?
|
| Hyaluronic Acid | 1 | 2019 | 96 | 0.150 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2018 | 101 | 0.150 |
Why?
|
| Animals | 18 | 2023 | 34303 | 0.150 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2019 | 74 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 3600 | 0.150 |
Why?
|
| Molecular Imaging | 1 | 2018 | 63 | 0.140 |
Why?
|
| Lymphocytes | 1 | 2019 | 408 | 0.140 |
Why?
|
| Aged | 9 | 2014 | 19661 | 0.140 |
Why?
|
| Aged, 80 and over | 7 | 2014 | 6541 | 0.140 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2019 | 746 | 0.140 |
Why?
|
| Indoles | 1 | 2018 | 191 | 0.140 |
Why?
|
| Cell Differentiation | 5 | 2018 | 1910 | 0.140 |
Why?
|
| Neoadjuvant Therapy | 1 | 2019 | 344 | 0.140 |
Why?
|
| Phyllodes Tumor | 1 | 2017 | 11 | 0.140 |
Why?
|
| Janus Kinase 2 | 1 | 2018 | 131 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2019 | 217 | 0.130 |
Why?
|
| Organ Specificity | 1 | 2017 | 426 | 0.130 |
Why?
|
| Nuclear Proteins | 1 | 2023 | 1284 | 0.130 |
Why?
|
| Transcription Factors | 4 | 2023 | 2603 | 0.130 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2016 | 7 | 0.130 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2018 | 734 | 0.130 |
Why?
|
| Biopsy, Large-Core Needle | 2 | 2013 | 31 | 0.130 |
Why?
|
| Multimodal Imaging | 1 | 2017 | 114 | 0.130 |
Why?
|
| Lymphatic Metastasis | 4 | 2014 | 418 | 0.120 |
Why?
|
| Signal Transduction | 5 | 2021 | 4597 | 0.120 |
Why?
|
| Carcinogenesis | 1 | 2019 | 340 | 0.120 |
Why?
|
| Retrospective Studies | 6 | 2013 | 16342 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 690 | 0.120 |
Why?
|
| Extracellular Matrix | 2 | 2019 | 239 | 0.120 |
Why?
|
| Disease Progression | 5 | 2021 | 2084 | 0.120 |
Why?
|
| Lactation | 1 | 2016 | 191 | 0.110 |
Why?
|
| Thyroid Gland | 3 | 2021 | 104 | 0.110 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 376 | 0.110 |
Why?
|
| Parathyroidectomy | 2 | 2021 | 49 | 0.110 |
Why?
|
| Pathology, Surgical | 1 | 2014 | 19 | 0.110 |
Why?
|
| Radiography | 2 | 2013 | 802 | 0.110 |
Why?
|
| Chemokine CCL1 | 1 | 2013 | 4 | 0.110 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2013 | 59 | 0.110 |
Why?
|
| Fibroadenoma | 1 | 2013 | 9 | 0.100 |
Why?
|
| Mammary Glands, Human | 1 | 2013 | 79 | 0.100 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 5169 | 0.100 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 145 | 0.100 |
Why?
|
| Immunohistochemistry | 5 | 2007 | 1704 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 1245 | 0.100 |
Why?
|
| Axilla | 2 | 2008 | 39 | 0.090 |
Why?
|
| eIF-2 Kinase | 1 | 2011 | 36 | 0.090 |
Why?
|
| Mice, Nude | 3 | 2021 | 725 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 515 | 0.090 |
Why?
|
| Cell Movement | 4 | 2021 | 854 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 493 | 0.090 |
Why?
|
| Biopsy | 2 | 2018 | 1242 | 0.090 |
Why?
|
| Chromatin | 2 | 2024 | 579 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2010 | 9 | 0.080 |
Why?
|
| Lymphangitis | 1 | 2010 | 5 | 0.080 |
Why?
|
| Tissue Array Analysis | 2 | 2021 | 137 | 0.080 |
Why?
|
| Diagnostic Errors | 1 | 2014 | 330 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 2656 | 0.080 |
Why?
|
| Cytodiagnosis | 1 | 2009 | 19 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 1714 | 0.080 |
Why?
|
| Neoplasm Transplantation | 2 | 2021 | 384 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2024 | 3044 | 0.080 |
Why?
|
| Granular Cell Tumor | 1 | 2008 | 3 | 0.080 |
Why?
|
| Cell Proliferation | 4 | 2018 | 2377 | 0.070 |
Why?
|
| Trastuzumab | 2 | 2019 | 134 | 0.070 |
Why?
|
| Autophagy | 1 | 2011 | 395 | 0.070 |
Why?
|
| Sarcoidosis | 1 | 2008 | 61 | 0.070 |
Why?
|
| Keratins | 3 | 2019 | 54 | 0.070 |
Why?
|
| Carcinoma | 1 | 2010 | 289 | 0.070 |
Why?
|
| Neoplasm, Residual | 1 | 2007 | 121 | 0.070 |
Why?
|
| Prognosis | 4 | 2019 | 4684 | 0.070 |
Why?
|
| Pattern Recognition, Automated | 1 | 2007 | 49 | 0.070 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 2414 | 0.070 |
Why?
|
| Conization | 1 | 2006 | 4 | 0.060 |
Why?
|
| Models, Anatomic | 1 | 2007 | 100 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2011 | 818 | 0.060 |
Why?
|
| Endothelial Cells | 2 | 2023 | 505 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 914 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2007 | 225 | 0.060 |
Why?
|
| Tamoxifen | 2 | 2018 | 363 | 0.060 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 2004 | 8 | 0.060 |
Why?
|
| Clone Cells | 1 | 2024 | 168 | 0.060 |
Why?
|
| Mastectomy | 1 | 2024 | 64 | 0.050 |
Why?
|
| Margins of Excision | 1 | 2024 | 51 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2005 | 430 | 0.050 |
Why?
|
| Artificial Intelligence | 1 | 2007 | 245 | 0.050 |
Why?
|
| Neoplasm Grading | 2 | 2014 | 276 | 0.050 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2023 | 38 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2005 | 874 | 0.050 |
Why?
|
| Gene Expression | 1 | 2007 | 1554 | 0.050 |
Why?
|
| Immunity | 1 | 2023 | 192 | 0.050 |
Why?
|
| Models, Biological | 1 | 2007 | 1465 | 0.050 |
Why?
|
| Cellular Reprogramming | 1 | 2023 | 113 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2023 | 298 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2013 | 1640 | 0.040 |
Why?
|
| RNA Interference | 2 | 2013 | 508 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2021 | 142 | 0.040 |
Why?
|
| Neoplasm Staging | 2 | 2014 | 1275 | 0.040 |
Why?
|
| Wnt Signaling Pathway | 1 | 2021 | 193 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 2005 | 1538 | 0.040 |
Why?
|
| Risk Factors | 2 | 2018 | 10282 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2021 | 971 | 0.040 |
Why?
|
| Uridine Diphosphate Glucuronic Acid | 1 | 2019 | 6 | 0.040 |
Why?
|
| Chorioallantoic Membrane | 1 | 2019 | 12 | 0.040 |
Why?
|
| Proteome | 1 | 2021 | 246 | 0.040 |
Why?
|
| Chick Embryo | 1 | 2019 | 131 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2024 | 887 | 0.040 |
Why?
|
| PPAR gamma | 1 | 2019 | 88 | 0.040 |
Why?
|
| Leukocyte Common Antigens | 1 | 2019 | 91 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 738 | 0.040 |
Why?
|
| Wnt1 Protein | 1 | 2018 | 71 | 0.040 |
Why?
|
| Pimozide | 1 | 2018 | 7 | 0.040 |
Why?
|
| Cell Separation | 1 | 2019 | 230 | 0.040 |
Why?
|
| Heterografts | 1 | 2018 | 175 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 1066 | 0.040 |
Why?
|
| Protein Array Analysis | 1 | 2018 | 101 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2018 | 222 | 0.040 |
Why?
|
| Hyperprolactinemia | 1 | 2018 | 22 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 368 | 0.040 |
Why?
|
| Age Factors | 1 | 2024 | 2815 | 0.040 |
Why?
|
| Risperidone | 1 | 2018 | 59 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2019 | 587 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 4407 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 2 | 2013 | 325 | 0.030 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2019 | 246 | 0.030 |
Why?
|
| Glycerophospholipids | 1 | 2017 | 7 | 0.030 |
Why?
|
| Glycolipids | 1 | 2017 | 32 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2017 | 105 | 0.030 |
Why?
|
| Sphingolipids | 1 | 2017 | 28 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 146 | 0.030 |
Why?
|
| Glucose Transporter Type 1 | 2 | 2006 | 24 | 0.030 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2017 | 152 | 0.030 |
Why?
|
| Estradiol | 1 | 2018 | 528 | 0.030 |
Why?
|
| Quinazolines | 1 | 2017 | 174 | 0.030 |
Why?
|
| Estrogens | 1 | 2018 | 503 | 0.030 |
Why?
|
| Phenotype | 1 | 2005 | 4271 | 0.030 |
Why?
|
| Young Adult | 1 | 2009 | 9058 | 0.030 |
Why?
|
| Genomics | 1 | 2023 | 1520 | 0.030 |
Why?
|
| Macrophages | 1 | 2019 | 626 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2017 | 344 | 0.030 |
Why?
|
| Antipsychotic Agents | 1 | 2018 | 374 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 2018 | 877 | 0.030 |
Why?
|
| Mutation | 2 | 2019 | 5906 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 586 | 0.030 |
Why?
|
| Phosphoproteins | 2 | 2006 | 420 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2014 | 89 | 0.030 |
Why?
|
| Diphenylamine | 1 | 2013 | 4 | 0.030 |
Why?
|
| Receptors, CCR8 | 1 | 2013 | 1 | 0.030 |
Why?
|
| Snail Family Transcription Factors | 1 | 2013 | 25 | 0.030 |
Why?
|
| Chemotactic Factors | 1 | 2013 | 17 | 0.030 |
Why?
|
| Endothelium, Lymphatic | 1 | 2013 | 10 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2013 | 8 | 0.030 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2013 | 42 | 0.030 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2013 | 42 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2013 | 60 | 0.030 |
Why?
|
| Lymphatic Vessels | 1 | 2013 | 37 | 0.030 |
Why?
|
| Chemotaxis | 1 | 2013 | 58 | 0.030 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2013 | 38 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2013 | 113 | 0.030 |
Why?
|
| Palliative Care | 1 | 2017 | 432 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2006 | 472 | 0.030 |
Why?
|
| Side-Population Cells | 1 | 2013 | 12 | 0.030 |
Why?
|
| CD24 Antigen | 1 | 2013 | 31 | 0.030 |
Why?
|
| Benzamides | 1 | 2013 | 110 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2017 | 509 | 0.030 |
Why?
|
| Hyaluronan Receptors | 1 | 2013 | 66 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 1762 | 0.030 |
Why?
|
| Histones | 2 | 2006 | 542 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2013 | 261 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2013 | 236 | 0.020 |
Why?
|
| Trans-Activators | 2 | 2006 | 801 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 246 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 1078 | 0.020 |
Why?
|
| Adolescent | 1 | 2009 | 19419 | 0.020 |
Why?
|
| Inflammation | 1 | 2019 | 1447 | 0.020 |
Why?
|
| Apoptosis | 1 | 2018 | 1819 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 670 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2013 | 257 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2011 | 312 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2013 | 375 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2014 | 543 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 347 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2011 | 280 | 0.020 |
Why?
|
| Lymphangiogenesis | 1 | 2010 | 18 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 331 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 387 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 626 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2011 | 247 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2013 | 453 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 455 | 0.020 |
Why?
|
| Male | 3 | 2018 | 61448 | 0.020 |
Why?
|
| Cell Survival | 1 | 2011 | 820 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2006 | 2061 | 0.020 |
Why?
|
| Cytokines | 1 | 2013 | 1292 | 0.020 |
Why?
|
| Parathyroid Glands | 1 | 2007 | 28 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2011 | 887 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2007 | 272 | 0.020 |
Why?
|
| Cell Line | 1 | 2011 | 2756 | 0.020 |
Why?
|
| Melanoma | 1 | 2013 | 943 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2006 | 144 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 1985 | 0.010 |
Why?
|
| Hypoxia | 1 | 2006 | 249 | 0.010 |
Why?
|
| Reoperation | 1 | 2007 | 828 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2007 | 650 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2006 | 627 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2011 | 3756 | 0.010 |
Why?
|
| Pregnancy | 1 | 2016 | 7221 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2008 | 12273 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 2055 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2007 | 887 | 0.010 |
Why?
|